ENVIRONMENTAL EXPOSURE TO FUNCTION OF LUNG EPITHELIAL STEM CELL BIOLOGY
Dr Clare Weeden
Laboratory Head
The Walter and Eliza Hall Institute of Medical Research (WEHI)
Melbourne, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | March 2025
Dr Clare Weeden has recently commenced as a Laboratory Head at WEHI in 2025, supported by the CSL Centenary Fellowship.
Dr Weeden specialises in lung epithelial cell biology in the context of homeostasis, inflammation, and lung cancer, particularly in people who don’t smoke. Her work endeavours to understand how past environmental exposures shape the responses of lung cells and the molecular mechanisms underlying this cellular recall, with the aim to develop novel early detection strategies for lung disease.
Dr Weeden completed her PhD studying lung squamous cell carcinoma initiation and treatment with Professor Marie-Liesse Asselin-Labat at WEHI, where she discovered distinct DNA repair abilities in lung stem cells that enabled their susceptibility to cancer, published in PLOS Biology.
Dr Weeden conducted postdoctoral research at WEHI and found that the pre-existing lung immune microenvironment had lasting effects on tumour immunogenicity and response to immunotherapy, published in Cancer Cell. She then continued her research on early tumour biology in Professor Charles Swanton’s laboratory at the Francis Crick Institute, London, where she was part of a team discovery that air pollution triggers inflammatory signalling in the lung that awakens previously dormant cells to initiate lung cancers in people who don’t smoke, published in Nature.
Dr Weeden is the past recipient of prestigious fellowships (Marie Sklodowska Curie Actions, Lung Foundation Australia Deep Manchanda Early Career Fellowship), research grants (Cancer Research UK, Mark Foundation, Cure Cancer/Cancer Australia) and has published 36 research publications with over 1000 citations.
Source: supplied
-
Impact of Leukaemia Foundation’s Research Funding into Blood Cancer
Bill Stavreski is the Head of Research at the Leukaemia Foundation who talks about the research impact in recent years. The Foundation itself marks its 25th anniversary in 2025, having funded a wide range of health and medical research since 2000. With a focus on basic science, health services research, treatment, and care, the organisation has invested nearly $90 million (adjusted in current dollars terms) in approximately 370 research grants over the years.
-
Public health and research into Ear, Nose and Throat conditions
Associate Professor Paul Paddle is an Ear, Nose and Throat (ENT) surgeon, head and neck surgeon with fellowship training in Laryngology – Voice, airway and Swallowing disorders. Working at Monash Health and Monash Children’s hospital, Paul has extensive experience managing a wide range of paediatric ENT conditions, from neonates to adolescents. He is also an active researcher in paediatric obstructive sleep apnoea and sleep disorders.
-
Ocular disease and early onset myopia
Dr Mountford has successfully established Western Australia’s first and only ocular genetic screening platform using zebrafish and utilises this model to help elucidate some of the complex gene-environment interactions responsible for the development of myopia.
